Evidence map›Paper›PMID 24063974›Full record

ReviewTrends in endocrinology and metabolism: TEM2013

Influence of VMH fuel sensing on hypoglycemic responses.

Owen Chan, Robert Sherwin

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03161964 (Propranolol as a Treatment for Impaired Awareness of Hypoglycemia in Type 1 Diabetes), which is not on this map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03161964 phase2terminatednot on this mapstarted 2017, after this paper: background citation

Propranolol as a Treatment for Impaired Awareness of Hypoglycemia in Type 1 Diabetes

TypeinterventionalSponsorAnu SharmaRan2017 to 2019Enrolled2ConditionsType 1 Diabetes MellitusArmsPropranolol 80 Mg Oral Capsule, Extended Release, Placebo oral capsule
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. CB1Rs in VMH neurons regulate glucose homeostasis but not body weight.American journal of physiology. Endocrinology and metabolism · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Owen ChanYale University School of Medicine, Department of Internal Medicine, Section of Endocrinology, New Haven, CT 06520, USA.
Robert Sherwin
Yale University · US

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
GLUCOREGULATORY HORMONE INTERACTIONS IN DIABETESR37DK020495 · NIDDK · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 1995 to 2012
$7.3M
GLUCOREGULATORY HORMONE INTERACTIONS IN DIABETESR01DK020495 · NIDDK · YALE UNIVERSITY · PI ROTHMAN, DOUGLAS LYLE · 1986 to 2022
$6.6M
MECHANISMS OF COUNTERREGULATORY FAILURER01DK099315 · NIDDK · YALE UNIVERSITY · PI CHAN, OWEN · 2013 to 2017
$1.8M
NIDDK NIH HHS P30 DK045735NIDDK NIH HHS P30 DK45735NIDDK NIH HHS R01 DK020495NIDDK NIH HHS R01 DK099315NIDDK NIH HHS R37 DK020495NIDDK NIH HHS R37 DK20495
6 · The paper itself

Abstract

Hypoglycemia produces complex neural and hormonal responses that restore glucose levels to normal. Glucose, metabolic substrates and their transporters, neuropeptides and neurotransmitters alter the firing rate of glucose-sensing neurons in the ventromedial hypothalamus (VMH); these monitor energy status and regulate the release of neurotransmitters that instigate a suitable counter-regulatory response. Under normal physiological conditions, these mechanisms maintain blood glucose concentrations within narrow margins. However, antecedent hypoglycemia and diabetes can lead to adaptations within the brain that impair counter-regulatory responses. Clearly, the mechanisms employed to detect and regulate the response to hypoglycemia, and the pathophysiology of defective counter-regulation in diabetes, are complex and need to be elucidated to permit the development of therapies that prevent or reduce the risk of hypoglycemia.

Indexed as

AnimalsBlood GlucoseHumansHypoglycemiaHypothalamusNeurotransmitter AgentsBlood GlucoseNeurotransmitter Agentsbraindiabetesglucose sensinghypoglycemiarecurrent hypoglycemiaventromedial hypothalamus

Identifiers

PMID24063974
PMCPMC3909530
OpenAlexW2017737209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.